-Event to be webcast live and a replay will be available
SAN RAFAEL, Calif., Aug. 19, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time. The event will feature presentations from members of the executive management team and will highlight BioMarin's pipeline, strategic plans, growth opportunities and long-term financial outlook.
BioMarin will host a live webcast on Wednesday, September 4, 2024, at approximately 10:30 am Eastern Daylight Time. Presentation materials will also be available at investors.biomarin.com. A replay of the webcast will be available online shortly after the live webcast is completed.
About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit .
Contacts: |
|
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:
SOURCE BioMarin Pharmaceutical Inc.
活動將於現場直播,並提供回放。
加利福尼亞州聖拉斐爾,2024年8月19日 /美通社/ - 生物瑪瑞製藥公司(BioMarin Pharmaceutical Inc.) (納斯達克: BMRN)將於2024年9月4日星期三上午10:30至下午1:00在紐約市舉行投資者日,會議邀請財務分析師和機構投資者參加。這次活動將由執行管理團隊成員主持演講,並突出展示BioMarin的流水線、戰略計劃、增長機會和長期財務展望。
生物瑪瑞將於2024年9月4日星期三上午10:30(美國東部夏令時)進行現場網絡直播。演示材料也將在investors.biomarin.com上提供。現場網絡直播結束後不久,將提供在線回放。
關於BioMarin
生物瑪瑞成立於1997年,是一家全球生物技術公司,致力於通過基因發現改變人類生活。公司開發和商業化旨在解決遺傳性疾病根本原因的定向療法。生物瑪瑞在研究和開發方面具有無與倫比的能力,已成功開發出八種顛覆性商業療法,用於罕見遺傳病人治療。公司獨特的藥物發現方法產生了一個多樣化的流水線,涵蓋商業、臨床和臨床前候選者,解決了重大的醫學需求,其生物學得到很好的理解,並提供了成爲市場領先或比現有治療方案提供重大優勢的機會。欲了解更多信息,請訪問。
聯繫人: |
|
投資者 | 媒體 |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650)374-2803 |
查看下載多媒體原始內容:
信息來源:BioMarin製藥公司。